Abevmy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Abevmy, covering 2026-01-28 to 2026-07-07. Get the full timeline:
Most recent: EMA Authorised: Abevmy (bevacizumab) — Biosimilar Collaborations Ireland Limited